Clinical Trials
5 trialsNCT02166658 2018-01-23
CaBaMet
AIO-Studien-gGmbH
Phase 2 Terminated
NCT01438307 2017-05-24
Phase II Study of Cabazitaxel-XRP6258 in Advanced Non-Small Cell Lung Cancer
University of Alabama at Birmingham
Phase 2 Completed
NCT01852578 2015-09-28
Cabazitaxel in Relapsed and Metastatic NSCLC
Hellenic Oncology Research Group
Phase 2 Completed
NCT01500720 2015-04-13
Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer
Sanofi
Phase 2 Completed
NCT01913067 2014-07-24
CRANIAL
Jules Bordet Institute
Phase 2 Withdrawn